Location, exposure, and conservation of neutralizing and nonneutralizing epitopes on human immunodeficiency virus type 2 SU glycoprotein

Journal of Virology

Volumn 70, Issue 7, 1996, Pages 4598-4606

  McKnight, Áine ^a   Shotton, Christine ^a   Cordell, Jacky ^a   Jones, Ian ^b   Simmons, Graham ^a   Clapham, Paul R ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b NATURAL ENVIRONMENT RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; EPITOPE; NEUTRALIZING ANTIBODY; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ANTIBODY COMBINING SITE; ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 2; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; RAT; STRAIN DIFFERENCE; VIRUS NEUTRALIZATION; VIRUS TYPING;

EID: 0029887105     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.7.4598-4606.1996     Document Type: Article

References (77)

1. Babas, T., S. Benichou, D. Guetard, L. Montagnier, and E. Bahraoui. 1994. Specificity of antipeptide antibodies produced against V2 and V3 regions of the external envelope of human immunodeficiency virus type 2. Mol. Immunol. 31:361-369.
2. Babu, P. G., N. K. Saraswithi, F. Devapriya, and T. J. John. 1993. The detection of HIV-2 infection in southern India. Indian J. Med. Res. 97:49-52.
3. Benichou, S., R. Legrand, N. Nakagawa, T. Faure, F. Traincard, G. Vogt, D. Dormont, P. Tiollais, M. P. Kieny, and P. I. Madaule. 1992. Identification of a neutralizing domain in the external envelope glycoprotein of simian immunodeficiency virus. AIDS Res. Hum. Retroviruses 8:1165-1170.
4. Bjorling, E., K. Broliden, D. Bernardi, G. Utter, R. Thorstensson, F. Chiodi, and E. Norrby. 1991. Hyperimmune antisera against synthetic peptides representing the glycoprotein of human immunodeficiency virus type 2 can mediate neutralization and antibody-dependent cytotoxic activity. Proc. Natl. Acad. Sci. USA 88:6082-6086.
5. Bjorling, E., F. Chiodi, G. Utter, and E. Norrby. 1994. Two neutralizing domains in the V3 region in the envelope glycoprotein gp125 of HIV type 2. J. Immunol. 152:1952-1959.
6. Bou-Habib, D. C., G. Roderiquez, T. Oravecz, P. W. Berman, P. Lusso, and M. A. Norcross. 1994. Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization. J. Virol. 68:6006-6013.
7. Breuer, J., N. W. Douglas, N. Goldman, and R. S. Daniels. 1995. Human immunodeficiency virus type 2 (HIV-2) env gene analysis: prediction of glycoprotein epitopes important for heterotypic neutralization and evidence for three genotype clusters within the HIV-2a subtype. J. Gen. Virol. 76:333-345.
8. Broliden, P. A., B. Makitalo, L. Akerblom, J. Rosen, K. Broliden, G. Utter, M. Jondal, E. Norrby, and B. Wahren. 1991. Identification of amino acids in the V3 region of gp120 critical for virus neutralization by human HIV-1specitic antibodies. Immunology 73:371-376.
9. Broliden, P. A., A. von-Gegerfelt, P. Clapham, J. Rosen, E. M. Fenyo, B. Wahren, and K. Broliden. 1992. Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins. Proc. Natl. Acad. Sci. USA 89:461-465.
10. Clapham, P. R., D. Blanc, and R. A. Weiss. 1991. Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by simian immunodeficiency virus. Virology 181:703-715.
11. Clapham, P. R., A. McKnight, and R. A. Weiss. 1992. Human immunodeficiency virus type 2 infection and fusion of CD4-negative human cell lines: induction and enhancement by soluble CD4. J. Virol. 66:3531-3537.
12. Clapham, P. R., R. A. Weiss, A. G. Dalgleish, M. Exley, D. Whitby, and N. Hogg. 1987. Human immunodeficiency virus infection of monocytic and T-lymphocytic cells: receptor modulation and differentiation induced by phorbol ester. Virology 158:44-51.
13. Clavel, F., M. Guyader, D. Guetard, M. Salle, L. Montagnier, and M. Alizon. 1986. Molecular cloning and polymorphism of the human immunodeficiency virus type 2. Nature (London) 324:691-695.
14. Clavel, F., K. Mansinho, S. Chamaret, D. Guetard, V. Favier, J. Nina, M. O. Santos Ferreira, J. L. Champalimaud, and L. Montagnier. 1987. Human immunodeficiency virus type 2 infection associated with AIDS in West Africa. N. Engl. J. Med. 316:1180-1185.
15. Cordell, J., P. Moore, D. C. Dean, P. J. Klasse, R. A. Weiss, and J. A. McKeating. 1991. Rat monoclonal antibodies to nonoverlapping epitopes of human immunodeficiency' virus type 1 gp120 block CD4 binding in vitro. Virology 185:72-79.
16. Davis, D., D. M. Stephens, C. A. Carne, and P. J. Lachmann. 1993. Antisera raised against the second variable region of the external envelope glycoprotein of human immunodeficiency virus type 1 cross-neutralize and show an increased neutralization index when they act together with antisera to the V3 neutralization epitope. J. Gen. Virol. 74:2609-2617.
17. Dean, C. J., L. A. Gyure, J. G. Hall, and J. M. Styles. 1986. Production of IgA-secreting rat × rat hybridomas. Methods Enzymol. 121:52-59.
18. Denis, F., F. Barin, G. Gershy-Damet, J. L. Rey, M. Lhuillier, M. Mounier, G. Leonard, A. Sangare, A. Goudeau, S. M'Boup, and P. Kanki. 1987. Prevalence of human T-lymphotropic retroviruses type III (HIV) and type IV in Ivory Coast. Lancet i:408-411.
19. de Wolf, F., R. H. Meloen, M. Bakker, F. Barin, and J. Goudsmit. 1991. Characterization of human antibody-binding sites on the external envelope of human immunodeficiency virus type 2. J. Gen. Virol. 72:1261-1267.
20. Emery, V. 1991. Baculovirus expression vectors. Generating a recombinant baculovirus, p. 309-318. In M. K. L. Collins (ed.). Methods in molecular virology, vol. 8. Viral vectors for gene expression. Humana Press, Clifton, N.J.
21. Franchini, G., K. A. Fargnoli, F. Giombini, L. Jagodzinski, A. de Rossi, M. Bosch, G. Biberfeld, E. M. Fenyo, J. Albert, R. C. Gallo, and F. Wong-Staal. 1989. Molecular and biological characterization of a replication competent human immunodeficiency type 2 (HIV-2) proviral clone. Proc. Natl. Acad. Sci. USA 86:2433-2437.
22. Fung, M. S., C. R. Sun, W. L. Gordon, R. S. Liou, T. W. Chang, W. N. Sun, E. S. Daar, and D. D. Ho. 1992. Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120. J. Virol. 66:848-856.
23. Goudsmit, J., C. Debouck, R. H. Meloen, L. Smit, M. Bakker, D. M. Asher, A. V. Wolff, C. J. Gibbs, Jr., and D. C. Gajdusek. 1988. Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. Proc. Natl. Acad. Sci. USA 85:4478-4482.
24. Grez, M., U. Dietrich, P. Balfe, H. von-Briesen-H, J. K. Maniar, G. Mahambre, E. L. Delwart, J. I. Mullins, and H. Rubsamen-Waigmann. 1994. Genetic analysis of human immunodeficiency virus type 1 and 2 (HIV-1 and HIV-2) mixed infections in India reveals a recent spread of HIV-1 and HIV-2 from a single ancestor for each of these viruses. J. Virol. 68:2161-2168.
25. Guyader, M., M. Emerman, P. Sonigo, F. Clavel, L. Montagnier, and M. Alizon. 1987. Genome organization and transactivation of the human immunodeficiency virus type 2. Nature (London) 326:662-669
26. Haigwood, N. L., J. R. Shuster, G. K. Moore, H. Lee, P. V. Skiles, K. W. Higgins, P. J. Barr, C. G. Nascimento, and K. S. Steimer. 1990. Importance of hypervariable regions of HIV-1 gp120 in the generation of virus neutralizing antibodies. AIDS Res. Hum. Retroviruses 6:855-869.
27. Ho, D. D., M. S. Fung, Y. Z. Cao, X. L. Li, C. Sun, T. W. Chang, and N. C. Sun. 1991. Another discontinuous epitope on glycoprotein gp120 that is important in human immunodeficiency virus type 1 neutralization is identified by a monoclonal antibody. Proc. Natl. Acad. Sci. USA 88:8949-8952.
28. Ho, D. D., J. A. McKeating, X. L. Li, T. Moudgil, E. S. Daar, N. C. Sun, and J. E. Robinson. 1991. Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody. J. Virol. 65:489-493.
29. Hoxie, J. A 1991. Hypothetical assignment of intrachain disulfide bonds for HIV-2 and SIV envelope glycoproteins. AIDS. Res. Hum. Retroviruses 7:495-499.
30. Javaherian, K., A. J. Langlois, G. J. La Rosa, A. T. Profy, D. P. Bolognesi, W. C. Herlihy, S. D. Putney, and T. J. Matthews. 1990. Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1. Science 250:1590-1593.
31. Javaherian, K., A. J. Langlois, C. McDanal, K. L. Ross, L. I. Eckler, C. L. Jellis, A. T. Profy, J. R. Rusche, D. P. Bolognesi, S. D. Putney, and T. J. Matthews. 1989. Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Proc. Natl. Acad. Sci. USA 86:6768-6772.
32. Javaherian, K., A. J. Langlois, D. C. Montefiori, K. A. Kent, K. A. Ryan, P. D. Wyman, J. Stott, D. P. Bolognesi, M. M. Corb, and G. J. Larosa. 1994. Studies of the conformation-dependent neutralizing epitopes of simian immunodeficiency virus envelope protein. J. Virol. 68:2624-2631.
33. Javaherian K., A. J. Langlois, S. Schmidt, M. Kaufmann, N. Cates, J. P. Langedijk, R. H. Meloen, D. C. Desrosiers, D. P. Burns, D. P. Bolognesi, et al. 1992. The principal neutralization determinant of simian immunodeficiency virus differs from that of human immunodeficiency virus type I. Proc. Natl. Acad. Sci. USA 89:1418-1422.
34. Rang, C. Y., K. Hariharan, M. R. Posner, and P. Nara. 1993. Identification of a new neutralizing epitope conformationally affected by the attachment of CD4 to gp120. J. Immunol. 151:449-457.
35. Kang, C. Y., P. Nara, S. Chamat, V. Caralli, T. Ryskamp, N. Haigwood, R. Newman, and H. E. Kohler. 1991. Evidence for non-V3-specific neutralizing antibodies that interfere with gp120/CD4 binding in human immunodeficiency virus 1-infected humans. Proc. Natl. Acad. Sci. USA 88:6171-6175.
36. Kanki, P. J., F. Barin, S. M'Boup, J. S. Allan, J. L. Romet Lemonne, R. Marlink, M. F. McLane, T. H. Lee, B. Arbeille, F. Denis, and M. Essex. 1986. New human T-lymphotropic retrovirus related tu simian T-lymphotropic virus type III (STLV-IIIAGM). Science 232:238-243.
37. Kent, K. A., L. Gritz, G. Stallard, M. P. Cranage, C. Collignon, C. Thiriart, T. Corcoran, P. Silvera, and E. J. Statt. 1991. Production of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins. AIDS 5:829-836.
38. Kent, K. A., E. Rud, T. Corcoran, C. Powell, C. Thiriart, C. Collignon, and E. J. Stott. 1992 Identification of two neutralizing and 8 non-neutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies. AIDS Res. Hum. Retroviruses 8:1147-1151.
39. Kodama, T., D. P. W. Burns, D. P. Silva, F. D. Veronese, and R. C. Desrosiers. 1991. Strain-specific neutralizing determinant in the transmembrane protein of simian immunodeficiency virus. J. Virol. 65:2010-2018.
40. Kulkarni, S., M. Thakar, J. Rodrigues, and K. Banerjee. 1992. HIV-2 antibodies in serum samples from Maharashtra state. Indian J. Med. Res. 95: 213-215.
41. Lasky, L. A., G. Nakamura, D. H. Smith, C. Fennie, C. Shimasaki, E. Patzer, P. Herman, T. Gregory, and D. J. Capon. 1987. Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell 50:975-985.
42. Luo, L., Y. Li, P. M. Cannon, S. Kim, and C. Y. Kang. 1992. Chimeric gag-V3 virus-like particles of human immunodeficiency virus induce virus-neutralizing antibodies. Proc. Natl. Acad. Sci. USA 89:10527-10531.
43. Matsushita, S., M. R. Guroff, J. Rusche, A. Koito, T. Hattori, H. Hoshino, K. Javaherian, K. Takatsuki, and S. Putney. 1988. Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope. J. Virol. 62:2107-2114.
44. Matsushita, S., S. Matsumi, K. Yoshimura, T. Morikita, T. Murakami and K. Takatsuki. 1995. Neutralizing monoclonal antibodies against human immunodeficiency virus type 2 gp120. J. Virol. 69:3333-3340.
45. Matthews, T. J., A. J. Langlois, W. G. Robey, N. T. Chang, R. C. Gallo, P. J. Fischinger, and D. P. Bolognesi. 1986. Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein. Proc. Natl. Acad. Sci. USA 83:9709-9713.
46. McKeating, J. A., J. Cordell, C. J. Dean, and P. Balfe. 1992. Synergistic interaction between ligands binding to the CD4 binding site and V3 domain of human immunodeficiency virus type I gp120. Virology 191:732-742.
47. McKeating, J. A., C. Shotton, J. Cordell, S. Graham, P. Balfe, N. Sullivan, M. Charles, M. Page, A. Bolmstedt, S. Olofsson, S. C. Kayman, Z. Wu, A. Pinter, C. Dean, J. Sodroski, and R. A. Weiss. 1993. Characterization of neutralizing monoclonal antibodies to linear and conformation-dependent epitopes within the first and second variable domains of human immunodeficiency virus type I gp120. J. Virol. 67:4932-4944.
48. McKnight, A., P. R. Clapham, and R. A. Weiss. 1994. HIV-2 and SIV infection of nonprimate cell lines expressing human CD4: restrictions to replication at distinct stages. Virology 201:8-18.
49. Moore, J. P., Y. Cao, L. Qing, Q. J. Sattentau, J. Pyati, R. Koduri, J. Robinson, C. F. Barbas 3rd, D. R. Burton, and D. D. Ho. 1995. Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120. J. Virol. 69:101-109.
50. Moore, J. P., Q. J. Sattentau, R. Wyatt, and J. Sodroski. 1994. Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies. J. Virol. 68:469-484.
51. Moore, J. P., Q. J. Sattentau, H. Yoshiyama, M. Thali, M. Charles, N. Sullivan, S. W. Poon, M. S. Fung, F. Traincard, M. Pinkus, G. Robey, J. E. Robinson, D. D. Ho, and J. Sodroski. 1993. Probing the structure of the V2 domain of human immunodeficiency virus type I surface glycoprotein gp120 with a panel of eight monoclonal antibodies: human immune response to the V1 and V2 domains. J. Virol. 67:6136-6151.
52. Moore, J. P., A. Trkola, B. Korber, L. J. Boots, J. A. Kessler 2nd, F. E. McCutchan, J. Mascola, D. D. Ho, J. Robinson, and A. J. Conley. 1995. A human monoclonal antibody to a complex epitope in the V3 region of gp120 of human immunodeficiency virus type I has broad reactivity within and outside clade B. J. Virol. 69:122-130.
53. Morikawa, Y., J. P. Moore, E. Fenouillet, and I. M. Jones. 1992 Complementation of human immunodeficiency virus glycoprotein mutations in trans. J. Gen. Virol. 73:1907-1913.
54. Muster, T., F. Steindl, M. Purtscher, A. Trkola, A. Klima, G. Himmler, F. Ruker, and H. Katinger. 1993. A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J. Virol. 67:6642-6647.
55. Nandi, J., H. Kamat, V. Bhavalkar, and K. Banerjee. 1994. Detection of human immunodeficiency virus antibody among homosexual men from Bombay. Sex. Transm. Dis. 21:235-236.
56. Norrby, E., P. Putkonen, B. Bottiger, G. Utter, and G. Biberfeld. 1991. Comparison of linear antigenic sites in the envelope proteins of human immunodeficiency virus (HIV) type 2 and type 1. AIDS Res. Hum. Retroviruses 7:279-285.
57. Palker, T. J., M. E. Clark, A. J. Langlois, T. J. Matthews, K. J. Weinhold, R. R. Randall, D. P. Bolognesi, and B. F. Haynes. 1988. Type-specific neutralization of the human immunodeficiency virus with antibodies to envencoded synthetic peplides. Proc. Natl. Acad. Sci. USA 85:1932-1936.
58. Pfutzner, A., U. Dietrich, U. von Eichel, H. von Briesen, H. D. Brede, J. K. Maniar, and H. Rubsamen-Waigmann. 1992. HIV-1 and HIV-2 infections in a high-risk population in Bombay, India: evidence for the spread of HIV-2 and presence of a divergent HIV-1 subtype. J. Acquired Immune Defic. Syndr. 5:972-977.
59. Pichard, E., A. Guindo, G. Grossetete, Y. Fofana, Y. I. Maiga, B. Koumare, S. Traore, M. Maiga, F. Brun Vezinet, and M. Rosenheim. 1988. Human immunodeficiency virus (HIV) infection in Mali. Med. Trop. (Marseilles) 48:345-349.
60. Robert-Guroff, M., K. Aldrich, R. Muldoon, T. L. Stern, G. P. Bansal, T. J. Matthews, P. D. Markham, R. C. Gallo, and G. Franchini. 1992. Crossneutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates. J. Virol. 66:3602-3608.
61. Rubsamen-Waigmann, H., H. V. Briesen, J. K. Maniar, P. K. Rao, C. Scholz, and A. Pfutzner. 1991. Spread of HIV-2 in India. Lancet 337:550-551.
62. Rubsamen-Waigmann, H., J. Maniar, S. Gerte, H. D. Brede, U. Dietrich, G. Mahambre, and A. Pfutzner. 1994. High proportion of HIV-2 and HIV-1/2 double-reactive sera in two Indian states, Maharashtra and Goa: first appearance of an HIV-2 epidemic along with an HIV-1 epidemic outside of Africa. Int. J. Med. Microbiol. Virol. Parasitol. Infect. Dis. 280:398-402.
63. Schulz, T. F., D. Whitby, J. G. Hoad, T. Corrah, H. Whittle, and R. A. Weiss. 1990. Biological and molecular variability of human immunodeficiency virus type 2 isolates from The Gambia. J. Virol. 64:5177-5182.
64. Schutten, M., A. McKnight, R. C. Huisman, M. Thali, J. A. McKeating, J. Sodroski, J. Goudsmit, and A. D. Osterhaus. 1993. Further characterization of an antigenic site of HIV-1 gp120 recognized by virus neutralizing human monoclonal antibodies. AIDS 7:919-923.
65. Shotton, C., C. Arnold, Q. Sattentau, J. Sodroski, and J. A. McKeating. 1995. Identification and characterization of monoclonal antibodies specific for polymorphic antigenic determinants within the V2 region of the human immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 69:222-230.
66. Smallman-Raynor, M., and A. Cliff. 1991. The spread of human immunodeficiency virus type 2 into Europe: a geographical analysis. Int. J. Epidemiol. 20:480-489.
67. Steimer, K. S., C. J. Scandella, P. V. Skiles, and N. L. Haigwood. 1991. Neutralization of divergent HIV-1 isolates by conformation-dependent human antibodies to Gp120. Science 254:105-108.
68. Sullivan, N., Y. Sun, J. Li, W. Hofmann, and J. R. Sodroski. 1995. Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. J. Virol. 69:4413-4422.
69. Sun, N. C., D. D. Ho, C. R. Sun, R. S. Liou, W. Gordon, M. S. Fung, X. L. Li, R. C. Ting, T. H. Lee, N. T. Chang, and T.-W. Chang. 1989. Generation and characterization of monoclonal antibodies to the putative CD4-binding domain of human immunodeficiency virus type I gp120. J. Virol. 63:3579-3585.
70. Thali, M., J. P. Moore, C. Furman, M. Charles, D. D. Ho, J. Robinson, and J. Sodroski. 1993. Characterization of conserved human immunodeficiency virus type I gp120 neutralization epitopes exposed upon gp120-CD4 binding. J. Virol. 67:3978-3988.
71. Thali, M., U. Olshevsky, C. Furman, D. Gabuzda, M. Posner, and J. Sodroski. 1991. Characterization of a discontinuous human immunodeficiency virus type I gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody. J. Virol. 65:6188-6193.
72. Torres, J. V., A. Malley, B. Banapour, D. E. Anderson, M. K. Axthelm, M. B. Gardner, and E. Benjamini. 1993. An epitope on the surface envelope glycoprotein (gp130) of simian immunodeficiency virus (SIVmac) involved in viral neutralization and T cell activation. AIDS Res. Hum. Retroviruses 9:423-430.
73. Traincard, F., M. A. Rey-Cuille, I. Huon, S. Dartevelle, J. C. Mazie, and S. Benichou. 1994. Characterization of monoclonal antibodies to human immunodeficiency virus type 2 envelope glycoproteins. AIDS. Res. Hum. Retroviruses 10:1659-1667.
74. Warrier, S. V., A. Pinter, W. J. Honnen, M. Girard, E. Muchmore, and S. A. Tilley. 1994. A novel, glycan-dependent epitope in the V2 domain of human immunodeficiency virus type 1 gp120 is recognized by a highly potent, neutralizing chimpanzee monoclonal antibody. J. Virol. 68:4636-4642.
75. Weiss, R. A., P. R. Clapham, J. N. Weber, D. Whilby, R. S. Tedder, T. O'Connor, S. Chamaret, and L. Montagnier. 1988. HIV-2 antisera crossneutralize HIV-1. AIDS 2:95-100.
76. Wu, Z., S. C. Kayman, W. Honnen, K. Revesz, H. Chen, S. Vijh Warrier, S. A. Tilley, J. McKeating, C. Shotton, and A. Pinter. 1995. Characterization of neutralization epitopes in the V2 region of human immunodeficiency virus type 1 gp120: role of glycosylation in the correct folding of the V1/V2 domain. J. Virol. 69:2271-2278.
77. Zwart, G., H. Langedijk, L. van der Hoek, J. J. de Jong, T. F. Wolfs, C. Ramautarsing, M. Bakker, A. de Ronde, and J. Goudsmit. 1991. Immunodominance and antigenic variation of the principal neutralization domain of HIV-1. Virology 181:481-489.